Cargando…
Recombinant Antibody Fragments for Neurodegenerative Diseases
BACKGROUND: Recombinant antibody fragments are promising alternatives to full-length immunoglobulins and offer important advantages compared with conventional monoclonal antibodies: extreme specificity, higher affinity, superior stability and solubility, reduced immuno-genicity as well as easy and i...
Autores principales: | Manoutcharian, Karen, Perez-Garmendia, Roxanna, Gevorkian, Goar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771054/ https://www.ncbi.nlm.nih.gov/pubmed/27697033 http://dx.doi.org/10.2174/1570159X01666160930121647 |
Ejemplares similares
-
Pyroglutamate-Modified Amyloid Beta Peptides: Emerging Targets for Alzheimer´s Disease Immunotherapy
por: Perez-Garmendia, Roxanna, et al.
Publicado: (2013) -
Neoantigen Cancer Vaccines: Real Opportunity or Another Illusion?
por: Manoutcharian, Karen, et al.
Publicado: (2021) -
Amyloid-β Peptide Binds to Cytochrome C Oxidase Subunit 1
por: Hernandez-Zimbron, Luis Fernando, et al.
Publicado: (2012) -
LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of Nutraceuticals
por: Catorce, Miryam Nava, et al.
Publicado: (2016) -
Evaluation of Anti-inflammatory Nutraceuticals in LPS-induced Mouse Neuroinflammation Model: An Update
por: Catorce, Miryam Nava, et al.
Publicado: (2020)